800
Views
12
CrossRef citations to date
0
Altmetric
Review

Oral chemotherapy for the treatment of hepatocellular carcinoma

&
Pages 993-1001 | Received 14 Mar 2018, Accepted 17 May 2018, Published online: 18 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Honghong Shen, Xianhua Gu, Huiyuan Li, Mingyue Tang, Xinwei Li, Yue Zhang, Fang Su & Zishu Wang. (2023) Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model. Journal of Hepatocellular Carcinoma 10, pages 327-345.
Read now
Xudong Liu, Jie Gao, Yaohui Sun, Feng Zhang, Wenzhi Guo & Shuijun Zhang. (2022) Clotrimazole Inhibits HCC Migration and Invasion by Modulating the ERK-p65 Signaling Pathway. Drug Design, Development and Therapy 16, pages 863-871.
Read now

Articles from other publishers (10)

Yuan Lin, Yimin Zhang, Zhuang Xiong, Min Wu, Muling Zeng, Chuangnan Li, Fujin Liu, Yazhi Liao, Chunping Liu & Jing Chen. (2023) Development of glycyrrhetinic acid ligand-functionalized liposomes for targeting hepatocellular carcinoma: Synthesis, preparation, characterization, and evaluation. Arabian Journal of Chemistry 16:10, pages 105131.
Crossref
Hu Li, Pengbo Hu, Yajun Zou, Lijuan Yuan, Yucheng Xu, Xiaohui Zhang, Xiaoyan Luo & Zhiqiang Zhang. (2023) Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug. Frontiers in Oncology 13.
Crossref
Chun‐Bo Yang, Han‐Xin Feng & Chao‐Liu Dai. (2022) Development and validation of an immune‐related prognosis signature associated with hypoxia and ferroptosis in hepatocellular carcinoma. Cancer Medicine 11:11, pages 2329-2341.
Crossref
Shanshan Deng, Antonio Solinas & Diego F. Calvisi. (2021) Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models. Frontiers in Oncology 11.
Crossref
John R. Bergquist, Amy Y. Li, Christopher S. Javadi, Byrne Lee, Jeffrey A. Norton, George A. Poultsides, Monica M. Dua & Brendan C. Visser. (2021) Regional lymph node sampling in hepatoma resection: insight into prognosis. HPB 23:9, pages 1360-1370.
Crossref
Jing Wang, Yuqi Wang, Haiqiang Cao, Hong Wang, Jie Li, Youxin Li, Yaping Li & Zhiwen Zhang. (2020) Orally delivered legumain-activated nanovehicles improve tumor accumulation and penetration for combinational photothermal-chemotherapy. Journal of Controlled Release 323, pages 59-70.
Crossref
An Zhou, Li Tang, Shuo Zeng, Yuanyuan Lei, Shiming Yang & Bo Tang. (2020) Gut microbiota: A new piece in understanding hepatocarcinogenesis. Cancer Letters 474, pages 15-22.
Crossref
Tao-Li Liu, Li-Na Zhang, Yue-Yu Gu, Mei-Gui Lin, Jun Xie, Yu-ling Chen, Jia-Hui Liu, Xin-Lin Wu & Sui-Lin Mo. (2020) The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4 In Vivo . Advances in Medicine 2020, pages 1-15.
Crossref
Takafumi Koyama, Shunsuke Kondo, Toshio Shimizu, Yutaka Fujiwara, Chigusa Morizane, Yasunari Sakamoto, Takuji Okusaka & Noboru Yamamoto. (2019) Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials. Frontiers in Oncology 9.
Crossref
Luca Rinaldi, Veronica Folliero, Luciana Palomba, Carla Zannella, Rachele Isticato, Raffaele Di Francia, Massimiliano Berretta, Ilario de Sio, Luigi E. Adinolfi, Giancarlo Morelli, Secondo Lastoria, Lucia Altucci, Carlo Pedone, Massimiliano Galdiero & Gianluigi Franci. (2018) Sonoporation by microbubbles as gene therapy approach against liver cancer. Oncotarget 9:63, pages 32182-32190.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.